Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Nishi

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Kidney International|January 26, 2016
Angiopoietin-like protein 2 and kidney fibrosis: lessons from knockout miceHiroshi Nishi
Kidney International|November 25, 2019
Porcupine's dilemma in kidney fibrosisHiroshi Nishi
Kidney International|April 24, 2022
Lay A TRAP for myeloid cell response in diabetic kidney diseaseHiroshi Nishi
Clinical Calcium|December 4, 2004
[Clinical application of calcimimetics]Hiroshi Nishi, Masafumi Fukagawa
Frontiers in Immunology|October 3, 2022
The role of the complement system in kidney glomerular capillary thrombosisYoko Yoshida, Hiroshi Nishi
Current Opinion in Rheumatology|December 13, 2018
Neutrophils in lupus nephritisHiroshi Nishi, Tanya N Mayadas
Nutrients|July 24, 2019
Lipotoxicity in Kidney, Heart, and Skeletal Muscle DysfunctionHiroshi Nishi, Takaaki Higashihara, Reiko Inagi
Expert Opinion on Pharmacotherapy|July 12, 2024
A spotlight on using HIF-PH inhibitors in renal anemiaMotoki Odawara, Hiroshi Nishi, Masaomi Nangaku
Clinical and Experimental Nephrology|June 27, 2007
Pathogenesis and prognosis of thrombotic microangiopathyMasaomi Nangaku, Hiroshi Nishi, Toshiro Fujita
Expert Opinion on Biological Therapy|November 14, 2025
Non-canonical function of erythropoietin and downstream effects of erythropoietin-mediated signaling beyond its role in erythropoiesisMotoki Odawara, Hiroshi Nishi, Masaomi Nangaku
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Kidney International|January 26, 2016
Angiopoietin-like protein 2 and kidney fibrosis: lessons from knockout miceHiroshi Nishi
Kidney International|November 25, 2019
Porcupine's dilemma in kidney fibrosisHiroshi Nishi
Kidney International|April 24, 2022
Lay A TRAP for myeloid cell response in diabetic kidney diseaseHiroshi Nishi
Clinical Calcium|December 4, 2004
[Clinical application of calcimimetics]Hiroshi Nishi, Masafumi Fukagawa
Frontiers in Immunology|October 3, 2022
The role of the complement system in kidney glomerular capillary thrombosisYoko Yoshida, Hiroshi Nishi
Current Opinion in Rheumatology|December 13, 2018
Neutrophils in lupus nephritisHiroshi Nishi, Tanya N Mayadas
Nutrients|July 24, 2019
Lipotoxicity in Kidney, Heart, and Skeletal Muscle DysfunctionHiroshi Nishi, Takaaki Higashihara, Reiko Inagi
Expert Opinion on Pharmacotherapy|July 12, 2024
A spotlight on using HIF-PH inhibitors in renal anemiaMotoki Odawara, Hiroshi Nishi, Masaomi Nangaku
Clinical and Experimental Nephrology|June 27, 2007
Pathogenesis and prognosis of thrombotic microangiopathyMasaomi Nangaku, Hiroshi Nishi, Toshiro Fujita
Expert Opinion on Biological Therapy|November 14, 2025
Non-canonical function of erythropoietin and downstream effects of erythropoietin-mediated signaling beyond its role in erythropoiesisMotoki Odawara, Hiroshi Nishi, Masaomi Nangaku
Pageof 8